Brian Feroldi

Brian Feroldi


Brian Feroldi has been covering the healthcare and technology industries for the Motley Fool since 2015. Brian's investing goal is to find the highest quality companies that he can find, buy them, and then to sit back and let compounding work its magic. See all of his articles here and make sure you follow him on Twitter.

Recent articles

Why Novocure Stock Briefly Fell Today

Shares initially plunged following the company's quarterly results. Were the numbers bad, or is something else impacting the stock price?

Why CVS Health Dropped Today

Several health insurance stocks took a step back on Monday following Nevada's caucus results.

3 Great Diabetes-Focused Stocks

According to The American Diabetes Association, every $1 in $7 spent in healthcare is spent on diabetes or its complications. We look at three companies well-positioned to capture this market.

Why Appian Stock Is Plunging Today

Shares fall after the company's quarterly results and guidance come up short, but there's more to the story than meets the eye.

3 Exciting Healthcare Stocks

We take a look at three small and promising healthcare companies across diagnostics, surgical products, and genetic testing.